SEQOMBIX
LIVE

Serial Number

87781740

Owner

CELLTRION, INC.

Attorney

Kisuk Lee

Filing Date

Feb 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SEQOMBIX Trademark

Serial Number: 87781740 • Registration: 6197810

SEQOMBIX is a trademark filed by CELLTRION, INC. on February 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Trademark Details

Filing Date

February 2, 2018

Registration Date

November 17, 2020

Published for Opposition

September 1, 2020

Goods & Services

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 17, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 17, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2020 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2020 RCSC
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Oct 8, 2019 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
Oct 8, 2019 LOPT
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 2, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 28, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 28, 2018 GNSL
SUSPENSION LETTER WRITTEN
Aug 28, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2018 CRFA
ASSIGNED TO LIE
Aug 23, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2018 CNRT
ASSIGNED TO EXAMINER
May 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2018 NWOS
NEW APPLICATION ENTERED
Feb 6, 2018 NWAP